Medical Lasers

Korean Society for Laser Medicine and Surgery (대한의학레이저학회)
권호 표지
DOI QR코드

DOI QR Code

Perioral Hyperpigmentation Treated with 1,064-nm Q-switched Neodymium:Yttrium-aluminum-garnet Laser Toning

  • Kim, Wan Jin (Department of Dermatology, Hanyang University Medical Center, Myongji Hospital) ;
  • Cho, Han Kyoung (Department of Dermatology, Hanyang University Medical Center, Myongji Hospital) ;
  • Lee, Sang Ju (Yonsei Star Skin & Laser Clinic)
  • Received : 2021.02.03
  • Accepted : 2021.03.04
  • Published : 2021.03.31
⟨ Previous Next ⟩

Abstract

The perioral region, which is one of the most conspicuous parts of the face, plays a significant role in interpersonal communication. However, the perioral region is highly susceptible to scarring and pigmentation and is difficult to treat. The causes of perioral hyperpigmentation are many, including physiologic reasons, systemic diseases, drugs, and infections. In the treatment of perioral hyperpigmentation, the cause of the disease must be diagnosed first. Management includes lifestyle modifications such as reducing the UVA exposure time, use of topical treatments including hydroquinone and retinoids, and physical therapy including laser therapy. We report a case of perioral hyperpigmentation treated with 1,064-nm Q-switched neodymium:yttrium-aluminum-garnet laser toning.

Keywords

References

  1. Copcu E, Tugay C, Tugay G. Idiopathic isolated perioral hyperpigmentation and treatment with the erbium:YAG laser. Lasers Med Sci 2004;18:223-6. https://doi.org/10.1007/s10103-003-0276-4
  2. Lenane P, Powell FC. Oral pigmentation. J Eur Acad Dermatol Venereol 2000;14:448-65. https://doi.org/10.1046/j.1468-3083.2000.00143.x
  3. Vashi NA, Kundu RV. Facial hyperpigmentation: causes and treatment. Br J Dermatol 2013;169 Suppl 3:41-56. https://doi.org/10.1111/bjd.12536
  4. Grunebaum LD, Smith JE, Hoosien GE. Lip and perioral trauma. Facial Plast Surg 2010;26:433-44. https://doi.org/10.1055/s-0030-1267717
  5. Orringer JS. Nonablative laser and light-based therapy: cosmetic and medical indications. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al, editors. Fitzpatrick's dermatology. 9th ed. New York: McGraw-Hill; 2019. p.3846-56.
  6. James WD, Elston DM, Treat J, Rosenbach MA, Neuhaus IM. Andrews' diseases of the skin: clinical dermatology. 13th ed. Edinburgh: Elsevier; 2019. p.909-21.
  7. Arora P, Sarkar R, Garg VK, Arya L. Lasers for treatment of melasma and post-inflammatory hyperpigmentation. J Cutan Aesthet Surg 2012;5:93-103. https://doi.org/10.4103/0974-2077.99436
  8. Sim JH, Park YL, Lee JS, Lee SY, Choi WB, Kim HJ, et al. Treatment of melasma by low-fluence 1064 nm Q-switched Nd:YAG laser. J Dermatolog Treat 2014;25:212-7. https://doi.org/10.3109/09546634.2012.735639
  9. Wong Y, Lee SS, Goh CL. Hypopigmentation induced by frequent low-fluence, large-spot-size QS Nd:YAG laser treatments. Ann Dermatol 2015;27:751-5. https://doi.org/10.5021/ad.2015.27.6.751